For patients experiencing mild to moderate GI symptoms, initial management should focus on non-pharmacological interventions, including smaller and more frequent meals, avoidance of high-fat or spicy foods, cessation of eating upon early satiety, and adequate hydration and fiber intake
GLP-1s target underlying causes like obesity but dont directly treat the airway blockages that cause OSA
News Release: Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial
Medication Alternatives: We can explore safe, effective, and affordable treatment options tailored to your specific goals
Heres the key concept Two people can arrive at the same LDL number later in life but the one who lowered LDL earlier carries far less plaque decades later